New Jersey Center for Cancer Research /ID# 1128-0493 — Brick, New Jersey

New Jersey Center for Cancer Research /ID# 1128-0493 is a clinical research site located in Brick, New Jersey, United States 08724.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

New Jersey Center for Cancer Research /ID# 1128-0493 has participated in 1 clinical trials.

Therapeutic areas: Metastatic Renal Cell Carcinoma, Advanced Urothelial Carcinoma, Advanced Gastric Adenocarcinoma.

Sponsors: Pharmacyclics LLC..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Brick

Browse all research sites in New Jersey · View every site in Brick

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New Jersey Center for Cancer Research /ID# 1128-0493?

New Jersey Center for Cancer Research /ID# 1128-0493 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New Jersey Center for Cancer Research /ID# 1128-0493 conducted?

New Jersey Center for Cancer Research /ID# 1128-0493 has 1 clinical trials on record. Their work covers Metastatic Renal Cell Carcinoma, Advanced Urothelial Carcinoma, Advanced Gastric Adenocarcinoma.

Is New Jersey Center for Cancer Research /ID# 1128-0493 accredited by Crixeo Clinical Trials?

New Jersey Center for Cancer Research /ID# 1128-0493 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New Jersey Center for Cancer Research /ID# 1128-0493?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.